Exercise for Cardiovascular Disease Prevention and Treatment From Molecular to Clinical, Part 1

(Elle) #1

226



  1. Ramasamy R, Oates PJ, Schaefer S (1997) Aldose reductase inhibition protects diabetic and
    nondiabetic rat hearts from ischemic injury. Diabetes 46:292–300

  2. Candido R, Forbes JM, Thomas MC et al (2003) A breaker of advanced glycation end prod-
    ucts attenuates diabetes-induced myocardial structural changes. Circ Res 92:785–792

  3. Li J, Schmidt AM (1997) Characterization and functional analysis of the promoter of RAGE,
    the receptor for advanced glycation end products. J Biol Chem 272:16498–16506

  4. Kislinger T, Tanji N, Wendt T et  al (2001) Receptor for advanced glycation end products
    mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic
    apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 21:905–910

  5. Basta G, Lazzerini G, Massaro M et al (2002) Advanced glycation end products activate
    endothelium through signal-transduction receptor RAGE: a mechanism for amplification of
    inflammatory responses. Circulation 105:816–822

  6. Bucciarelli LG, Wendt T, Qu W et al (2002) RAGE blockade stabilizes established athero-
    sclerosis in diabetic apolipoprotein E-null mice. Circulation 106:2827–2835

  7. Goldin A, Beckman JA, Schmidt AM et al (2006) Advanced glycation end products: sparking
    the development of diabetic vascular injury. Circulation 114:597–605

  8. Koves TR, Ussher JR, Noland RC et al (2008) Mitochondrial overload and incomplete fatty
    acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7:45–56

  9. Sarkar P, Kar K, Mondal MC et al (2010) Elevated level of carbonyl compounds correlates
    with insulin resistance in type 2 diabetes. Ann Acad Med Singap 39:904–909

  10. Raposeiras-Roubin S, Rodino-Janeiro BK, Grigorian-Shamagian L et al (2011) Relation of
    soluble receptor for advanced glycation end products to predict mortality in patients with
    chronic heart failure independently of Seattle heart failure score. Am J Cardiol 107:938–944

  11. Basta G, Sironi AM, Lazzerini G et  al (2006) Circulating soluble receptor for advanced
    glycation end products is inversely associated with glycemic control and S100A12 protein.
    J Clin Endocrinol Metab 91:4628–4634

  12. Yonekura H, Yamamoto Y, Sakurai S et  al (2003) Novel splice variants of the receptor for
    advanced glycation endproducts expressed in human vascular endothelial cells and pericytes,
    and their putative roles in diabetes-induced vascular injury. Biochem J 370:1097–1109

  13. Choi KM, Han KA, Ahn HJ et al (2012) Effects of exercise on sRAGE levels and cardio-
    metabolic risk factors in patients with type 2 diabetes: a randomized controlled trial. J Clin
    Endocrinol Metab 97:3751–3758

  14. Wright KJ, Thomas MM, Betik AC et al (2014) Exercise training initiated in late middle age
    attenuates cardiac fibrosis and advanced glycation end-product accumulation in senescent
    rats. Exp Gerontol 50:9–18

  15. Botta A, Laher I, Beam J et al (2013) Short term exercise induces PGC-1alpha, ameliorates
    inflammation and increases mitochondrial membrane proteins but fails to increase respiratory
    enzymes in aging diabetic hearts. PLoS One 8:e70248

  16. Boor P, Celec P, Behuliak M et  al (2009) Regular moderate exercise reduces advanced
    glycation and ameliorates early diabetic nephropathy in obese Zucker rats. Metabolism
    58:1669–1677

  17. Buse MG (2006) Hexosamines, insulin resistance, and the complications of diabetes: current
    status. Am J Physiol Endocrinol Metab 290:E1–E8

  18. Housley MP, Rodgers JT, Udeshi ND et al (2008) O-GlcNAc regulates FoxO activation in
    response to glucose. J Biol Chem 283:16283–16292

  19. Lunde IG, Aronsen JM, Kvaloy H et al (2012) Cardiac O-GlcNAc signaling is increased in
    hypertrophy and heart failure. Physiol Genomics 44:162–172

  20. Erickson JR, Pereira L, Wang L et al (2013) Diabetic hyperglycaemia activates CaMKII and
    arrhythmias by O-linked glycosylation. Nature 502:372–376

  21. Belke DD (2011) Swim-exercised mice show a decreased level of protein O-GlcNAcylation
    and expression of O-GlcNAc transferase in heart. J Appl Physiol (1985) 111:157–162

  22. Bennett CE, Johnsen VL, Shearer J et al (2013) Exercise training mitigates aberrant cardiac
    protein OGlcNAcylation in streptozotocin-induced diabetic mice. Life Sci 92:657–663


A.M. Mahmoud
Free download pdf